Skip to Content

Zinplava Prices, Coupons and Patient Assistance Programs

Zinplava (bezlotoxumab) is a member of the immune globulins drug class and is commonly used for Prevention of Clostridioides difficile Infection Recurrence.

Zinplava Prices

The cost for Zinplava intravenous solution (25 mg/mL) is around $3,977 for a supply of 40 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Zinplava price guide is based on using the discount card which is accepted at most U.S. pharmacies.

Intravenous Solution

25 mg/mL Zinplava intravenous solution
from $3,976.70 for 40 milliliters
Quantity Per unit Price
40 milliliters $99.42 $3,976.70

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee. Printable Discount Card

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Zinplava Coupons and Rebates

Zinplava offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Zinplava Merck Co-Pay Assistance Program: Eligible commercially insured patients will pay $0 per infusion and with a maximum benefit of $3,700 for one vial per calendar year; if 2 vials are required for one infusion then the maximum benefit is $7,500 per calendar year; for additional information contact the program at 877-709-4455.

Applies to:Zinplava
Number of uses:per prescription per calendar year
ExpiresMay 31, 2021

Patient Assistance Programs for Zinplava

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Merck Connect

Elligibility requirements:
  1. Determined case by case
  2. Not disclosed
  3. Medically Necessary as determined by a Doctor
  4. Must be treated by US licensed healthcare provider
  5. Resources for HEALTHCARE PROFESSIONALS ONLY. The Physician must register to access tools and materials for patient support, product sample requests, up-to-date professional resources, and other Merck professional sites.

Applicable drugs:

  • Zinplava (bezlotoxumab) Injection; IV

Provider: Merck Access Program for Zinplava

Elligibility requirements:
  1. Determined case by case
  2. Not disclosed
  3. Medically appropriate condition/diagnosis
  4. Must be residing in the US or a US territory, and under the care of a US physician
  5. Patient must sign the enrollment form to give the program permission to access their financial information in order to determine eligibility. Patients in need who appear not to qualify should still call. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.

Applicable drugs:

  • Zinplava (bezlotoxumab) Injection; IV